Literature DB >> 11587216

Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt's lymphoma.

D B Zimonjic1, C Keck-Waggoner, N C Popescu.   

Abstract

In this study, CA46 and ST486, two Epstein-Barr (EBV) negative cell lines derived from sporadic BL, were analyzed by multicolor spectral karyotyping, G-banding, fluorescence in situ hybridization with single-copy gene probes, and comparative genomic hybridization (CGH). In addition to reciprocal t(8;14)(q24;q32) translocation involving c-myc and IgH loci, we identified a t(7;8;14)(q11.2;q24;q32) translocation in CA 46 cells and t(8;14;18)(q24;q32;q23) in ST486 cells. Both rearrangements were not previously described in BL and resulted in transposition of myc sequences in a new genomic configuration. Several DNA imbalances mapped by CGH at the same sites in both lines, may reflect recurrent genomic changes that are relevant to pathogenesis of BL. We tested the tumorigenicity of these lines by injecting cells intraperitoneally in SCID mice. In two separate experiments, CA46 cells produced tumors 2 weeks after cell inoculation while ST486 cells induced only one tumor after a long latency period. Partial duplication of the long arm of chromosome 1 involving variable bands but always band 1q23 is the second most common alteration in BL and is known to be associated with aggressive tumors and poor prognosis. Duplication of the bands 1q23-24 commonly observed in EBV-negative lines was identified only in highly tumorigenic CA46 cells suggesting that this region harbor gene(s) associated with tumor cell invasiveness.

Entities:  

Mesh:

Year:  2001        PMID: 11587216     DOI: 10.1038/sj.leu.2402281

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.

Authors:  Drazen B Zimonjic; Marian E Durkin; Catherine L Keck-Waggoner; Sang-Won Park; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

2.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.

Authors:  Tapan K Bera; Drazen B Zimonjic; Nicholas C Popescu; Bangalore K Sathyanarayana; Vasantha Kumar; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

Review 4.  Intracellular Signaling Pathways Involved in Childhood Acute Lymphoblastic Leukemia; Molecular Targets.

Authors:  Cristian Fabián Layton Tovar; Hugo Mendieta Zerón
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-20       Impact factor: 0.900

5.  Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.

Authors:  Drazen B Zimonjic; Xiaoling Zhou; Ju-Seog Lee; Veronika Ullmannova-Benson; Veenu Tripathi; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

Review 6.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

Review 7.  t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.

Authors:  Delong Liu; Josif Shimonov; Suneeta Primanneni; Yongrong Lai; Tauseef Ahmed; Karen Seiter
Journal:  Mol Cancer       Date:  2007-06-04       Impact factor: 27.401

8.  Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.

Authors:  Pier Paolo Piccaluga; Mohsen Navari; Giulia De Falco; Maria Raffaella Ambrosio; Stefano Lazzi; Fabio Fuligni; Cristiana Bellan; Maura Rossi; Maria Rosaria Sapienza; Maria Antonella Laginestra; Maryam Etebari; Emily A Rogena; Lynnette Tumwine; Claudio Tripodo; Davide Gibellini; Jessica Consiglio; Carlo M Croce; Stefano A Pileri; Lorenzo Leoncini
Journal:  Oncotarget       Date:  2016-01-05

Review 9.  The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients.

Authors:  Justyna Derebas; Kinga Panuciak; Mikołaj Margas; Joanna Zawitkowska; Monika Lejman
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.